pharma · Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Bayer | Pharmaceuticals
Bayer Australia Ltd
Bayer Australia is a pharma organization headquartered in Pymble, AU. Primary therapeutic focus areas include Transthyretin Amyloid Cardiomyopathy (ATTR-CM). NovaPharmaNews links 2 clinical program(s), 10 drug profile(s)
Berlin, DE HQ
4 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Berlin, DE
- Employees
- 4
- Programs
- 2
- Drugs
- 15
- Patents
- 1
22049
Phase 1 · other · Advanced metastatic castration-resistant prostate cancer with prostate specific membrane antigen (PSMA) expression
22049 for Advanced metastatic castration-resistant prostate cancer with prostate specific membrane antigen (PSMA) expression is a Phase 1 program (other) at Bayer Australia Ltd with 1 ClinicalTrials.gov record(s).
Internal code 22049
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Bayer Australia Ltd
- Phase
- Phase 1
- Modality
- other
- Indication
- Advanced metastatic castration-resistant prostate cancer with prostate specific membrane antigen (PSMA) expression
- Status
- active
- Trials
- 1